Wanbury Limited has informed the Exchange regarding a press release dated October 12, 2026, titled "Press Release - Wanbury Skin Health Limited (Subsidiary of Wanbury Limited) Launches its berrysoft baby Product Range Across Multiple States in India, Marks Strategic Entry in The Paediatric Dermatology Segment.".
Filed with NSE · ISIN INE107F01022 · · 3 pages · English
Summary by 6ix AI
Wanbury Limited has announced the launch of its berrysoft baby product range through its subsidiary, Wanbury Skin Health Limited, marking a strategic entry into the paediatric dermatology segment. The product range is designed to meet everyday baby skincare and hygiene needs, with several items already launched and more in development. The company has obtained GST registration in multiple states and is in the process of acquiring additional licenses for its products.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Wanbury
- Wanbury Limited has informed the Exchange regarding a press release dated October 08, 2026, titled "Press Release regarding filing new Drug Master File (DMF) in South Africa for Tramadol HC1 API".
- Wanbury Limited Press Release Aug 13 2026
- Wanbury Limited Press Release Aug 11 2026
- Wanbury Limited Press Release Jul 30 2026
- Wanbury Limited Press Release Jun 25 2026
Later from Wanbury
- Wanbury Limited has informed the Exchange regarding a press release dated October 16, 2026, titled "Wanbury Limited Regulatory Progress in API Business, New Business Opportunities and Operational Achievements".
- Wanbury Limited has informed the Exchange regarding a press release dated October 19, 2026, titled "Wanbury Limited Awards for Tanuku and Patalganga Facilities".
Follow Wanbury into a list and get an email when it puts out news.
Follow Wanbury